{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:16:02Z","timestamp":1777947362734,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005162","name":"Meyer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["104,955\/Z\/14\/Z"],"award-info":[{"award-number":["104,955\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["211,496\/Z\/18\/Z"],"award-info":[{"award-number":["211,496\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["218,242\/Z\/19\/Z"],"award-info":[{"award-number":["218,242\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012007","name":"Rockefeller University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001642","name":"Glenn Foundation for Medical Research","doi-asserted-by":"publisher","award":["EQU201903007798"],"award-info":[{"award-number":["EQU201903007798"]}],"id":[{"id":"10.13039\/100001642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002350","name":"St. Giles Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris-Saclay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI088364"],"award-info":[{"award-number":["R01AI088364"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/P011705\/1"],"award-info":[{"award-number":["BB\/P011705\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/P023959\/1"],"award-info":[{"award-number":["BB\/P023959\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/R013071\/1"],"award-info":[{"award-number":["BB\/R013071\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-IAHU-01"],"award-info":[{"award-number":["ANR-10-IAHU-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX-62-IBEID"],"award-info":[{"award-number":["ANR-10-LABX-62-IBEID"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-20-COVI-0003"],"award-info":[{"award-number":["ANR-20-COVI-0003"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001621","name":"Fisher Center for Alzheimer&apos;s Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/S032304\/1"],"award-info":[{"award-number":["MR\/S032304\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019631","name":"SCOR Corporate Foundation for Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/D\/10,002,070"],"award-info":[{"award-number":["BBS\/E\/D\/10,002,070"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/D\/30,002,275"],"award-info":[{"award-number":["BBS\/E\/D\/30,002,275"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W005611\/1"],"award-info":[{"award-number":["MR\/W005611\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.retram.2022.103333","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T05:14:24Z","timestamp":1641791664000},"page":"103333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["A common TMPRSS2 variant has a protective effect against severe COVID-19"],"prefix":"10.1016","volume":"70","author":[{"given":"Alessia","family":"David","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Parkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erola","family":"Pairo-Castineira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarun","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelie","family":"Cobat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Tenesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Sancho-Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Abel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy S.","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.Kenneth","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael JE","family":"Sternberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2022.103333_bib0001","unstructured":"WHO. WHO Coronavirus (COVID-19) Dashboard [Internet]. Available from: https:\/\/covid19.who.int\/"},{"issue":"2","key":"10.1016\/j.retram.2022.103333_bib0002","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis","volume":"81","author":"Zheng","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.retram.2022.103333_bib0003","doi-asserted-by":"crossref","unstructured":"Zhang Q., Bastard P., Bolze A., Jouanguy E., Zhang S.-.Y., C.O.V.I.D. Human Genetic Effort, et\u00a0al. Life-threatening COVID-19: defective interferons unleash excessive inflammation. Med (N Y). 2020;1(1):14\u201320.","DOI":"10.1016\/j.medj.2020.12.001"},{"issue":"16","key":"10.1016\/j.retram.2022.103333_bib0004","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","article-title":"Genomewide association study of severe COVID-19 with respiratory failure","volume":"383","author":"D","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.retram.2022.103333_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104485","article-title":"Association between ABO blood groups and COVID-19 infection, severity and demise: a systematic review and meta-analysis","volume":"84","author":"Wu","year":"2020","journal-title":"Infect Genet Evol"},{"issue":"6515","key":"10.1016\/j.retram.2022.103333_bib0006","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"6515","key":"10.1016\/j.retram.2022.103333_bib0007","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.retram.2022.103333_bib0008","article-title":"Genetic mechanisms of critical illness in COVID-19","author":"Pairo-Castineira","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.retram.2022.103333_bib0009","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.retram.2022.103333_bib0010","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.retram.2022.103333_bib0011","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.02062-10","article-title":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry","volume":"85","author":"Shulla","year":"2011","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.retram.2022.103333_bib0012","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.retram.2022.103333_bib0013","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"issue":"17","key":"10.1016\/j.retram.2022.103333_bib0014","first-page":"4180","article-title":"Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2","volume":"59","author":"Lin","year":"1999","journal-title":"Cancer Res"},{"issue":"21","key":"10.1016\/j.retram.2022.103333_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00649-19","article-title":"TMPRSS2 is the major activating protease of influenza a virus in primary human airway cells and influenza B virus in human type II pneumocytes","volume":"93","author":"Limburg","year":"2019","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.retram.2022.103333_bib0016","first-page":"1686","article-title":"Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia","volume":"61","author":"Afar","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.retram.2022.103333_bib0017","article-title":"SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells","author":"Lukassen","year":"2020","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.retram.2022.103333_bib0018","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T","article-title":"Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues","volume":"193","author":"Vaarala","year":"2001","journal-title":"J Pathol"},{"issue":"7798","key":"10.1016\/j.retram.2022.103333_bib0019","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.retram.2022.103333_bib0020","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acschemneuro.0c00210","article-title":"Expression of the SARS-CoV-2 ENTRY PROTEINs, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age","volume":"11","author":"Bilinska","year":"2020","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1016\/j.retram.2022.103333_bib0021","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140766","article-title":"Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium","volume":"131","author":"Schuler","year":"2021","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.retram.2022.103333_bib0022","first-page":"93","article-title":"TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection","volume":"15","author":"Iwata-Yoshikawa","year":"2019","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.retram.2022.103333_bib0023","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/s41467-021-21171-x","article-title":"Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.retram.2022.103333_bib0024","doi-asserted-by":"crossref","DOI":"10.1038\/s41564-021-00908-w","article-title":"The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets","author":"Peacock","year":"2021","journal-title":"Nat Microbiol"},{"issue":"12","key":"10.1016\/j.retram.2022.103333_bib0025","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/JVI.00094-12","article-title":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry","volume":"86","author":"Kawase","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.retram.2022.103333_bib0026","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64508","article-title":"SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site","volume":"10","author":"Mykytyn","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.retram.2022.103333_bib0027","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2015.01.011","article-title":"Protease inhibitors targeting coronavirus and filovirus entry","volume":"116","author":"Zhou","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.retram.2022.103333_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103255","article-title":"Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity","author":"Hoffmann","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.retram.2022.103333_bib0029","unstructured":"ClinicalTrial. gov [Internet]. Available from: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=camostat&cntry=&state=&city=&dist="},{"issue":"6","key":"10.1016\/j.retram.2022.103333_bib0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis","volume":"10","author":"Kelley","year":"2015","journal-title":"Nat Protoc"},{"issue":"D1","key":"10.1016\/j.retram.2022.103333_bib0031","doi-asserted-by":"crossref","first-page":"D158","DOI":"10.1093\/nar\/gkw1099","article-title":"UniProt: the universal protein knowledgebase","volume":"45","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.retram.2022.103333_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.retram.2022.103333_bib0033","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.jmb.2019.04.009","article-title":"Can predicted protein 3D structures provide reliable insights into whether missense variants are disease associated?","volume":"431","author":"Ittisoponpisan","year":"2019","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/j.retram.2022.103333_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nprot.2015.123","article-title":"SIFT missense predictions for genomes","volume":"11","author":"Vaser","year":"2016","journal-title":"Nat Protoc"},{"issue":"4","key":"10.1016\/j.retram.2022.103333_bib0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"issue":"4","key":"10.1016\/j.retram.2022.103333_bib0036","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajhg.2011.03.004","article-title":"Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score,","volume":"88","author":"Gonz\u00e1lez-P\u00e9rez","year":"2011","journal-title":"Condel. Am J Hum Genet"},{"key":"10.1016\/j.retram.2022.103333_bib0037","doi-asserted-by":"crossref","first-page":"W382","DOI":"10.1093\/nar\/gki387","article-title":"The FoldX web server: an online force field","volume":"33","author":"Schymkowitz","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.retram.2022.103333_bib0038","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1038\/s41467-020-17409-9","article-title":"Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice","volume":"11","author":"McKay","year":"2020","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.retram.2022.103333_bib0039","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1534\/g3.118.200144","article-title":"Survey of human chromosome 21 gene expression effects on early development in Danio rerio","volume":"8","author":"Edie","year":"2018","journal-title":"G3 (Bethesda)"},{"issue":"9","key":"10.1016\/j.retram.2022.103333_bib0040","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","article-title":"Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies","volume":"50","author":"Zhou","year":"2018","journal-title":"Nat Genet"},{"issue":"17","key":"10.1016\/j.retram.2022.103333_bib0041","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","article-title":"METAL: fast and efficient meta-analysis of genomewide association scans","volume":"26","author":"Willer","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.retram.2022.103333_bib0042","article-title":"COVID-19 host genetics initiative. Mapping the human genetic architecture of COVID-19","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.retram.2022.103333_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"issue":"7675","key":"10.1016\/j.retram.2022.103333_bib0044","first-page":"204","article-title":"Laboratory, data analysis &coordinating center (LDACC)\u2014analysis working group, statistical methods groups\u2014analysis working group, enhancing GTEx (eGTEx) groups, NIH common fund, NIH\/NCI, et\u00a0al. Genetic effects on gene expression across human tissues","volume":"550","year":"2017","journal-title":"Nature."},{"issue":"10","key":"10.1016\/j.retram.2022.103333_bib0045","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0167-5699(97)01130-4","article-title":"CD6-ligand interactions: a paradigm for SRCR domain function?","volume":"18","author":"Aruffo","year":"1997","journal-title":"Immunol Today"},{"issue":"22","key":"10.1016\/j.retram.2022.103333_bib0046","doi-asserted-by":"crossref","first-page":"8810","DOI":"10.1073\/pnas.87.22.8810","article-title":"An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors","volume":"87","author":"Freeman","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.retram.2022.103333_bib0047","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0968-0004(94)90165-1","article-title":"The SRCR superfamily: a family reminiscent of the Ig superfamily","volume":"19","author":"Resnick","year":"1994","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.retram.2022.103333_bib0048","unstructured":"The National Genomic Research Library v5.1, Genomics England [Internet]. Available from: https:\/\/doi.org\/10.6084\/m9.figshare.4530893.v6 2020."},{"issue":"2","key":"10.1016\/j.retram.2022.103333_bib0049","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.retram.2022.103333_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110160","article-title":"Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: four hypotheses for possible explanation","volume":"144","author":"Yamamoto","year":"2020","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.retram.2022.103333_bib0051","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41421-020-00231-4","article-title":"Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility","volume":"6","author":"Wang","year":"2020","journal-title":"Cell Discov"},{"issue":"2","key":"10.1016\/j.retram.2022.103333_bib0052","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/bcpt.13533","article-title":"Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety","volume":"128","author":"Breining","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"6","key":"10.1016\/j.retram.2022.103333_bib0053","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00134-021-06395-1","article-title":"Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia","volume":"47","author":"Sakr","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.retram.2022.103333_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100849","article-title":"Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with COVID-19-a double-blind randomized controlled trial","volume":"35","author":"Gunst","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.retram.2022.103333_bib0055","unstructured":"Foipan dropped as potential coronavirus treatment [Internet]. Available from: https:\/\/www.thepharmaletter.com\/in-brief\/brief-foipan-dropped-as-potential-coronavirus-treatment"},{"issue":"Pt 3","key":"10.1016\/j.retram.2022.103333_bib0056","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1042\/BJ20041066","article-title":"The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells","volume":"388","author":"Wilson","year":"2005","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.retram.2022.103333_bib0057","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/j.pain.0000000000000130","article-title":"TMPRSS2, a novel membrane-anchored mediator in cancer pain","volume":"156","author":"Lam","year":"2015","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.retram.2022.103333_bib0058","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/002215549804600204","article-title":"Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues","volume":"46","author":"D'Andrea","year":"1998","journal-title":"J Histochem Cytochem"},{"issue":"6723","key":"10.1016\/j.retram.2022.103333_bib0059","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/18223","article-title":"A protective role for protease-activated receptors in the airways","volume":"398","author":"Cocks","year":"1999","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.retram.2022.103333_bib0060","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2004.07.060","article-title":"The role of protease activation of inflammation in allergic respiratory diseases","volume":"114","author":"Reed","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.retram.2022.103333_bib0061","article-title":"Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases","volume":"17","author":"Heuberger","year":"2019","journal-title":"Thromb J [Internet]."},{"issue":"4","key":"10.1016\/j.retram.2022.103333_bib0062","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.4049\/jimmunol.175.4.2598","article-title":"Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms","volume":"175","author":"Su","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.retram.2022.103333_bib0063","doi-asserted-by":"crossref","first-page":"L385","DOI":"10.1152\/ajplung.00098.2005","article-title":"Human airway trypsin-like protease stimulates human bronchial fibroblast proliferation in a protease-activated receptor-2-dependent pathway","volume":"290","author":"Matsushima","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1016\/j.retram.2022.103333_bib0064","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1165\/rcmb.2003-0199OC","article-title":"Human airway trypsin-like protease increases mucin gene expression in airway epithelial cells","volume":"30","author":"Chokki","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.retram.2022.103333_bib0065","article-title":"Structure, function and variants analysis of the androgen-regulated TMPRSS2, a drug target candidate for COVID-19 infection","author":"David","year":"2020","journal-title":"BioRxiv"},{"issue":"6","key":"10.1016\/j.retram.2022.103333_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104227","article-title":"Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19","volume":"64","author":"Monticelli","year":"2021","journal-title":"Eur J Med Genet"},{"issue":"1","key":"10.1016\/j.retram.2022.103333_bib0067","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3390\/genes12010019","article-title":"Structural variability, expression profile, and pharmacogenetic properties of TMPRSS2 gene as a potential target for COVID-19 therapy","volume":"12","author":"Zarubin","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.retram.2022.103333_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118313","article-title":"Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies","volume":"260","author":"Vargas-Alarc\u00f3n","year":"2020","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.retram.2022.103333_bib0069","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12916-020-01673-z","article-title":"New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis","volume":"18","author":"Hou","year":"2020","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.retram.2022.103333_bib0070","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1080\/07391102.2020.1767690","article-title":"First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations","volume":"39","author":"Paniri","year":"2021","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10.1016\/j.retram.2022.103333_bib0071","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12041-020-01217-7","article-title":"Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human","volume":"99","author":"Senapati","year":"2020","journal-title":"J Genet"},{"issue":"34","key":"10.1016\/j.retram.2022.103333_bib0072","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109229118","article-title":"Asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis","volume":"118","author":"Sah","year":"2021","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318622000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318622000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:39:57Z","timestamp":1762821597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318622000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2452318622000010"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2022.103333","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.04.21252931","asserted-by":"object"}]},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A common TMPRSS2 variant has a protective effect against severe COVID-19","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2022.103333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103333"}}